Stocks in news: Reliance Industries, HDFC, Tata Motors, SBI, Suzlon and more
Stocks in news: Info Edge, Reliance Industries, Ashok Leyland, HDFC, Tata Motors, SBI, Suzlon and more Stocks in news: Reliance Industries, HDFC, Tata Motors, SBI, Suzlon and more BusinessToday.In
Updated Jul 07, 2021, 9:49 AM IST
Benchmark indices were trading flat in early trade today. Sensex was up 9 points to 52,870 and Nifty gained 8 points to 15,825. Here s a look at stocks that are likely to remain in news today.
Info Edge: The company s board has cleared the acquisition of Doselect.com run by Axilly Labs Pvt. Ltd. Doselect offers technical assessment services for recruitment and learning purposes. Info Edge will acquire 100% share capital of Doselect.com on a fully diluted basis for Rs 21 crore.
Tata Motors Limited to issue NCDs worth ₹500 cr - The Hindu BusinessLine thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.
Shares of Tata Motors, on Tuesday, were up 3 per cent to Rs 332, while Tata Motors DVR (differential voting rights shares) hit a fresh 52-week high of Rs 156, up 3 per cent on the BSE in intra-day trade on Tuesday ahead of its January-March quarter (Q4FY21) earnings today. Tata Motors share hit a 52-week high of Rs 357 on March 3, 2021.
In today s meeting, the board would also consider a proposal for raising funds by way of issue of one or more instruments including convertible securities of any description or debt securities, through preferential issue, private placements, rights issue or any other methods or combination thereof in the domestic and/or international markets.
Dr Reddy s launches Sputnik V vaccine in India Drug firm Dr Reddy s Laboratories on Friday said it has launched COVID vaccine Sputnik V in the Indian market with the first dose being administered in Hyderabad, as part of a limited pilot. The company said the imported doses of the vaccine are presently priced at a maximum retail price of Rs 948, with 5 per cent GST per dose, amounting to Rs 995.4 per dose.
Moody’s upgrades outlook on Tata Motors Credit rating agency, Moody s Investors Service, has upgraded its outlook on Tata Motors to stable from negative and affirmed the company s B1 corporate family rating (CFR) and B1 senior unsecured ratings. The latest rating action follows Moody s affirmation and change in outlook to stable from negative on the B1 ratings of the company s UK subsidiary Jaguar Land Rover Automotive Plc (JLR) earlier this week.